- The use of fluorescence correlation spectroscopy to investigate binding site stoichiometry for monomeric and dimeric fluorescent ligands at the neuropeptide Y Y1 receptor
R. R. Richardson1, M. Groenen1, M. Liu2, S. Mountford2, S. Briddon1, P. Thompson2, N. Holliday1. 1SoLS; ICS, University of Nottingham, Nottingham, United Kingdom, 2medicinal chemistry, Monash University, Melbourne, Australia,
- The use of handheld computers for accessing medical mobile applications and investigative tools (MAP-IT) among pharmacists
NA Apidi, DD Lee, PSM Lai, TM Khan, LC Ming
- The use of hypnotics and mortality in a population-based retrospective cohort study
TY Lan, YF Zeng, GJ Tang
- The use of impedance assays to profile small molecules in a cell line natively expressing GPR43
T Cheung, L Dickson, P Mitchell
- The use of in vivo imaging technology to determine compound efficacy in a mouse lung infection model
Osborne Colin, Moffat Alex, Dean Charles, Woods Angela, Caughlan Ruth, Growcott Ellie, Banner Kathy
- The Use of In Vivo Imaging Technology to Track Inflammation Post Bacterial Challenge in a Mouse Lung Infection Model
Oviosu Y, Cufari K, Manni K, Growcott E, Curtis A, Galarneau JR, Krucker T, Osborne C
- The use of NanoBRET to determine the cooperative effects of allosteric modulators on the binding of a1 adenosine receptor agonists
S. L. Cooper1,2, M. Soave1,2, S. J. Hill1,2, J. Woolard1,2. 1Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom, 2Centre of Membrane Proteins and Receptors, University of Nottingham, Nottingham, United Kingdom
- The use of on-line video-based resources to support in vivo teaching
JE Keeble, M Nandi, J Clark, A King, S Pitchford, L Moon, P Thakore, F Russell, E Wilde, S Turnock, P Wallace, SD Brain, J Hall
- The use of selective inhibitors to estimation of cholinesterase activity of liver and muscle for food animals
Abass Askar K, Kudi C, Moody J
- The use of surrogate markers in european medicines agency fast track approval pathways-are they validated
C. S. Schuster Bruce1, P. McGettigan1, P. Brhlikova2. 1William Harvey Research Institute, London, United Kingdom, 2Newcastle University,, Newcastle, United Kingdom,
